Atara Bio announces positive interim results from ongoing phase 1 trial
Atara announced its collaborating investigators at the Queensland Institute of Medical Research and The University of Queensland are reporting interim Phase 1 trial results from the autologous version of ATA188, or autologous ATA188, in patients with primary or secondary progressive MS and SPMS. April 20, 2017